![Susan Doleman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Susan Doleman
Technik-/Wissenschafts-/F&E-Leiter bei
CYTEIR THERAPEUTICS, INC.
Profil
Susan Doleman is currently the Vice President-Clinical Operations at Cyteir Therapeutics, Inc. She previously worked as the Senior Director-Clinical Operations at Epizyme, Inc., a Scientist at The Children's Hospital Corp., and the Vice President-Clinical Development Operations at Replimune Group, Inc. Ms. Doleman received her undergraduate degree from Smith College.
Aktive Positionen von Susan Doleman
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.08.2019 |
Ehemalige bekannte Positionen von Susan Doleman
| Unternehmen | Position | Ende |
|---|---|---|
| EPIZYME, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
The Children's Hospital Corp.
 The Children's Hospital Corp. Hospital/Nursing ManagementHealth Services Operates pediatric hospitals | Technik-/Wissenschafts-/F&E-Leiter | - |
| REPLIMUNE GROUP, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Susan Doleman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
20
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Smith College
 Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital Corp.
The Children's Hospital Corp. Hospital/Nursing ManagementHealth Services Operates pediatric hospitals | Health Services |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology company | Health Technology |
